175 related articles for article (PubMed ID: 14662025)
21. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
[TBL] [Abstract][Full Text] [Related]
22. TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses.
Duraisingham SS; Hornig J; Gotch F; Patterson S
J Immunol; 2009 Aug; 183(4):2242-51. PubMed ID: 19625644
[TBL] [Abstract][Full Text] [Related]
23. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
Zhu M; Xu W; Su H; Huang Q; Wang B
Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
[TBL] [Abstract][Full Text] [Related]
24. T-cadinol and calamenene induce dendritic cells from human monocytes and drive Th1 polarization.
Takei M; Umeyama A; Arihara S
Eur J Pharmacol; 2006 May; 537(1-3):190-9. PubMed ID: 16631732
[TBL] [Abstract][Full Text] [Related]
25. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
26. Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.
Hansen M; Hjortø GM; Donia M; Met Ö; Larsen NB; Andersen MH; thor Straten P; Svane IM
Vaccine; 2013 Jan; 31(4):639-46. PubMed ID: 23200882
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
28. PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.
Muthuswamy R; Mueller-Berghaus J; Haberkorn U; Reinhart TA; Schadendorf D; Kalinski P
Blood; 2010 Sep; 116(9):1454-9. PubMed ID: 20498301
[TBL] [Abstract][Full Text] [Related]
29. Human dendritic cells engineered to express alpha tumor necrosis factor maintain cellular maturation and T-cell stimulation capacity.
Ye Z; Chen Z; Sami A; El-Gayed A; Xiang J
Cancer Biother Radiopharm; 2006 Dec; 21(6):613-22. PubMed ID: 17257077
[TBL] [Abstract][Full Text] [Related]
30. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes.
Tawab A; Fan Y; Read EJ; Kurlander RJ
Transfusion; 2009 Mar; 49(3):536-47. PubMed ID: 19243546
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
32. Comparison of media and serum supplementation for generation of monophosphoryl lipid A/interferon-γ-matured type I dendritic cells for immunotherapy.
Kolanowski ST; Sritharan L; Lissenberg-Thunnissen SN; Van Schijndel GM; Van Ham SM; ten Brinke A
Cytotherapy; 2014 Jun; 16(6):826-34. PubMed ID: 24529557
[TBL] [Abstract][Full Text] [Related]
33. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
34. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.
Nguyen-Pham TN; Yang DH; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Lee JJ
Cell Mol Immunol; 2012 Jan; 9(1):45-53. PubMed ID: 21822297
[TBL] [Abstract][Full Text] [Related]
35. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
36. A sea urchin lectin, SUL-1, from the Toxopneustid sea urchin induces DC maturation from human monocyte and drives Th1 polarization in vitro.
Takei M; Nakagawa H
Toxicol Appl Pharmacol; 2006 May; 213(1):27-36. PubMed ID: 16197973
[TBL] [Abstract][Full Text] [Related]
37. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.
Giordano D; Magaletti DM; Clark EA; Beavo JA
J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841
[TBL] [Abstract][Full Text] [Related]
38. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.
Kuroki H; Morisaki T; Matsumoto K; Onishi H; Baba E; Tanaka M; Katano M
Cancer Immunol Immunother; 2003 Sep; 52(9):561-8. PubMed ID: 14627128
[TBL] [Abstract][Full Text] [Related]
39. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
40. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
